Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKB-6548 in Anemia Secondary to CKD
NCT01235936Phase 2Completed
- Sponsor
- Akebia Therapeutics
- Start
- Oct 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Oct 2010; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01235936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235936.